Lionheart Health Named Finalist in Octane's 2025 Medical Technology Innovation Awards
Lionheart Health's recognition as a finalist in Octane's High Tech Awards highlights its breakthrough whole body regeneration chamber technology that could extend human healthspan by 20 years through AI-driven organ regeneration.
Lionheart Health, Inc. has been recognized as a finalist in the category of Best Innovation in Medical Technology Life Sciences in the prestigious High Tech Awards organized by Octane. This recognition underscores the company's commitment to driving breakthrough healthspan innovations and creating impactful solutions that benefit humankind through its advanced bioelectric and biologics technologies.
The company's flagship development is a whole body regeneration chamber described as a "womb for adults" designed to extend healthspan longevity by 20 years. Powered by AI and precise robotics, the multi-modality device uses bioelectrically-controlled and enhanced biologics intended to regenerate multiple organs in the human body, including hearts, kidneys, brains, livers, pancreas, lungs, and other vital systems.
Lionheart Health's primary business model involves licensing its patented technology platform to qualified clinics worldwide. The company has secured FDA 510K market clearances for using targeted bioelectric stimulation to improve circulation, build and recover muscle strength, reduce pain and inflammation, treat arthritis including joint osteoarthritis, prevent blood clots, enhance exercise benefits, and improve stroke recovery. These technologies are integrated into products for improving skin and hair health, sexual health vitality, joint pain recovery, rapid body toning, and chronic inflammation reduction.
The company's recent achievements include winning the AbbVie Allergan ULP Innovation in Medical Aesthetics Award, Medtech Outlook Stimulator Development of the Year 2025 Award, and being named one of 40 semi-finalists in the $101 million XPRIZE Healthspan Competition. Lionheart Health was also announced as a finalist for the Orange County Business Journal Innovator of the Year 2025 Award.
Lionheart Health is sponsoring The Klotho Conference in Irvine on September 15th and 16th, 2025. Visitors can register and learn more at https://www.klothoconference.com. The company's patented BodStim TM EMS suit has demonstrated the ability to increase circulating klotho levels substantially higher than ordinary exercise. More information is available at https://www.bodstim.com.
The Octane 2025 Technology Awards Ceremony will take place on Thursday, September 25th, 2025 in Irvine. This recognition positions Lionheart Health at the forefront of medical technology innovation with potential global implications for extending human healthspan and improving quality of life through regenerative medicine technologies.